[Immunology of Chronic Rhinosinusitis with Nasal Polyps As a Basis for Treatment with Biologicals]

Overview

Journal HNO

Specialty Otorhinolaryngology

Date 2018 Sep 1

PMID 30167718

Citations 6

Authors

L Klimek

M Koennecke

J Hagemann

B Wollenberg

S Becker

Affiliations

Soon will be listed here.

Abstract

Background: Chronic rhinosinusitis (CRS) is a heterogeneous and multifactorial inflammation of the nasal and paranasal mucosa. Until now, no internationally standardized classification could be developed. In most cases, CRS is phenotypically classified according to chronic rhinosinusitis with (CRScNP) and without nasal polyps (CRSsNP). However, recent studies could show that there are numerous endotypes within these phenotypes based on different inflammatory mechanisms. This review describes the important immunological mechanisms of CRScNP and highlights modern treatment options with biologicals directly addressing particular immunological processes.

Methods: Current knowledge on immunological and molecular processes of CRS, particularly CRScNP, was extracted from Medline, PubMed, national and international study- and guideline-registers, and the Cochrane library by a systematic review of the literature.

Results: Based on current literature, various immunological mechanisms for CRS and CRScNP could be identified. Relevant studies for the treatment of eosinophilic conditions such as asthma or CRScNP are presented and, if available, results of these studies are discussed.

Conclusion: The growing insight into the underlying immunological mechanisms of CRScNP could pave the way for new personalized treatment options such as biologicals in the future.

Citing Articles

Exploring E-Vape Aerosol Penetration into Paranasal Sinuses: Insights from Patient-Specific Models.

Seifelnasr A, Zare F, Si X, Xi J Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005957 PMC: 11858401. DOI: 10.3390/ph18020142.

A Supplement with Ribes Nigrum, Boswellia Serrata, Bromelain and Vitamin D to Stop Local Inflammation in Chronic Sinusitis: A Case-Control Study.

De Luca P, DAscanio L, Cingolani C, Latini G, Grigaliute E, Di Mauro P J Clin Med. 2023; 12(8).

PMID: 37109265 PMC: 10142908. DOI: 10.3390/jcm12082929.

Determination of orally administered 1,8-Cineol in nasal polyp tissues from chronic rhinosinusitis patients using gas chromatography: mass spectrometry.

MacKenzie C, Goerke T, Buecking M, Heidemann M, Leichtle A, Ringbeck B Sci Rep. 2023; 13(1):3605.

PMID: 36869061 PMC: 9984394. DOI: 10.1038/s41598-023-29941-x.

Klimek L, Forster-Ruhrmann U, Beule A, Chaker A, Hagemann J, Klimek F Allergo J. 2022; 31(6):24-39.

PMID: 36092307 PMC: 9441224. DOI: 10.1007/s15007-022-5080-1.

Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP).

Klimek L, Hagemann J, Welkoborsky H, Cuevas M, Casper I, Forster-Ruhrmann U Allergol Select. 2022; 6:148-166.

PMID: 35572064 PMC: 9097524. DOI: 10.5414/ALX02296E.

References

Lane P . Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J Exp Med. 2000; 191(2):201-6. PMC: 2195748. DOI: 10.1084/jem.191.2.201. View

Bachert C, Gevaert P, Holtappels G, Cuvelier C, Van Cauwenberge P . Nasal polyposis: from cytokines to growth. Am J Rhinol. 2000; 14(5):279-90. DOI: 10.2500/105065800781329573. View

Hurst S, Wilkinson T, McLoughlin R, Jones S, Horiuchi S, Yamamoto N . Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001; 14(6):705-14. DOI: 10.1016/s1074-7613(01)00151-0. View

Busse W, Corren J, Lanier B, McAlary M, Fowler-Taylor A, Cioppa G . Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001; 108(2):184-90. DOI: 10.1067/mai.2001.117880. View

Menzies-Gow A, Kay A, Robinson D . Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med. 2002; 167(2):199-204. DOI: 10.1164/rccm.200208-789OC. View

Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C . IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol. 2002; 24(1):25-9. DOI: 10.1016/s1471-4906(02)00013-3. View

Nutku E, Aizawa H, Hudson S, Bochner B . Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood. 2003; 101(12):5014-20. DOI: 10.1182/blood-2002-10-3058. View

Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E . Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2004; 114(4):851-7. DOI: 10.1016/j.jaci.2004.07.012. View

Kim S, Han S, Azam T, Yoon D, Dinarello C . Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005; 22(1):131-42. DOI: 10.1016/j.immuni.2004.12.003. View

10.

Meyer J, Bartels J, Gorogh T, Sticherling M, Rudack C, Ross D . The role of RANTES in nasal polyposis. Am J Rhinol. 2005; 19(1):15-20. View

11.

Holgate S, Djukanovic R, Casale T, Bousquet J . Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy. 2005; 35(4):408-16. DOI: 10.1111/j.1365-2222.2005.02191.x. View

12.

Corrigan C, Kettner J, Doemer C, Cromwell O, Narkus A . Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy. 2005; 60(6):801-7. DOI: 10.1111/j.1398-9995.2005.00790.x. View

13.

Chen Y, Arab S, Westhofen M, Lorenzen J . Expression of interleukin-5, interleukin-8, and interleukin-10 mRNA in the osteomeatal complex in nasal polyposis. Am J Rhinol. 2005; 19(2):117-23. View

14.

Scavuzzo M, Fattori B, Ruffoli R, Rocchi V, Carpi A, Berni R . Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis. Biomed Pharmacother. 2005; 59(6):323-9. DOI: 10.1016/j.biopha.2004.11.010. View

15.

Kostamo K, Sorsa T, Leino M, Tervahartiala T, Alenius H, Richardson M . In vivo relationship between collagenase-2 and interleukin-8 but not tumour necrosis factor-alpha in chronic rhinosinusitis with nasal polyposis. Allergy. 2005; 60(10):1275-9. DOI: 10.1111/j.1398-9995.2005.00888.x. View

16.

Jones S . Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005; 175(6):3463-8. DOI: 10.4049/jimmunol.175.6.3463. View

17.

Nutku E, Hudson S, Bochner B . Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. Biochem Biophys Res Commun. 2005; 336(3):918-24. DOI: 10.1016/j.bbrc.2005.08.202. View

18.

Danielsen A, Tynning T, Brokstad K, Olofsson J, Davidsson A . Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum. Eur Arch Otorhinolaryngol. 2006; 263(3):282-9. DOI: 10.1007/s00405-005-1031-1. View

19.

Netea M, Azam T, Lewis E, Joosten L, Wang M, Langenberg D . Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med. 2006; 3(8):e277. PMC: 1539091. DOI: 10.1371/journal.pmed.0030277. View

20.

Polzehl D, Moeller P, Riechelmann H, Perner S . Distinct features of chronic rhinosinusitis with and without nasal polyps. Allergy. 2006; 61(11):1275-9. DOI: 10.1111/j.1398-9995.2006.01132.x. View